Unmesh Lal 

Director, Healthcare & Life Sciences
Frost & Sullivan 

Unmesh Lal has 15+ years of healthcare industry expertise, comprising of strategy consulting, primarily with global life sciences companies. His expertise lies in tracking game changing companies, innovative business models and disruptive technologies while serving as a growth coach to clients in precision health. He has authored thought leadership and presented at leading industry events like J.P.Morgan, Bio-IT, Medica Health IT, Medtec, Precision Med Exhibition & Summit, Precision Medicine & Biomarkers Leaders Summit, Blockchain Congress, Basel Life etc. His in-depth understanding of the precision health ecosystem enables him to guide companies in identifying growth opportunities across Precision Screening & Diagnosis, Targeted Therapeutics, Surveillance & Monitoring, Discovery & Development Solutions/ Services etc. He holds a Master degree in Biomedical Engineering from the University of Michigan- Ann Arbor. 

Speech title & Synopsis

Growth Opportunities in Precision Health: Moving from Sickcare to Healthcare

Precision health, powered by the digital data revolution and scientific advances, is the beacon of hope in the rapidly changing healthcare landscape. It promises to usher in an era of proactive, personalized, and preventive healthcare, transforming the industry forever. With advancements in artificial intelligence, machine learning, and Big Data analytics, precision health has the potential to revolutionize when, where and how we prevent, diagnose, treat, and manage diseases. Below main issues will be addressed in this speech,
1. What is precision health and how it is different to precision medicine
2. What needs to happen to shift care from sick care to healthcare
3. What are the key technologies that are required to enable precision health
4. Where are the growth opportunities of Precision Health in 2030